SELLAS Life Sciences (SLS) Gross Margin (2012 - 2022)

SELLAS Life Sciences (SLS) reported Gross Margin of 90.0% for Q1 2022, down 825.0% year-over-year from 12.41% in Q1 2021, and down 5.0% on a QoQ basis from 94.74% in Q2 2021.

SELLAS Life Sciences (SLS) has 7 years of Gross Margin data on file, last reported at 90.0% in Q1 2022.

  • Quarterly Gross Margin fell 825.0% year-over-year to 90.0% in Q1 2022, while the trailing twelve-month figure through Dec 2022 was 90.0% (down 737.0% YoY) and the FY2022 annual result came in at 90.0%, down 737.0% from the prior year.
  • Gross Margin declined to 90.0% in Q1 2022 per SLS's latest filing, from 94.74% in the prior quarter.
  • Across five years, Gross Margin topped out at 100.0% in Q4 2020 and bottomed at 90.0% in Q1 2022.
  • The 3-year median for Gross Margin is 96.49% (2021), against an average of 95.75%.
  • Peak annual rise in Gross Margin reached 825 bps in 2022, while the deepest fall reached 825 bps in 2022.
  • Tracing SLS's Gross Margin over 3 years: stood at 100.0% in 2020, then decreased by 5 bps to 94.74% in 2021, then decreased by 5 bps to 90.0% in 2022.
  • Per Business Quant, the three latest SLS Gross Margin figures stand at 90.0% (Q1 2022), 94.74% (Q2 2021), and 98.25% (Q1 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 79.04%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 86.85%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 91.79%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 82.22%
10 SELLAS Life Sciences 1.61 Bn 1.61 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2022 90.00%
Jun 30, 2021 94.74%
Mar 31, 2021 98.25%
Dec 31, 2020 100.00%
Jun 30, 2015 86.16%
Mar 31, 2015 85.71%
Dec 31, 2014 85.04%
Sep 30, 2014 84.75%
Jun 30, 2014 85.11%
Mar 31, 2014 84.77%
Dec 31, 2013 91.80%
Sep 30, 2013 53.64%
Jun 30, 2013 100.00%
Mar 31, 2013 100.00%
Dec 31, 2012 100.00%